Emcure Pharma IPO

Emcure Pharma IPO will open for subscription from 03 July 2024. The company aims for an issue size of ₹1,952.03 Cr through this IPO.


Company Overview

Full nameEmcure Pharmaceuticals Limited
SectorHealthcare
IndustryPharmaceuticals & Drugs
Company Websitehttps://www.emcure.com/

About Company

Emcure Pharmaceuticals stands as a prominent Indian pharmaceutical entity, dedicated to the advancement, production, and global promotion of an extensive array of pharmaceutical products spanning various critical therapeutic domains. Functioning as a research and development (R&D) oriented enterprise, Emcure boasts a distinct product portfolio encompassing oral medications, injectables, and biotherapeutics. This diverse range has facilitated its market penetration into over 70 countries, establishing a robust presence in India, Europe, and Canada.

The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT FY 2024 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynecology and HIV antiviral therapeutic areas for the MAT FY 2024. As of 31 March 2024, the company had a team of 548 qualified scientists and five dedicated R&D facilities in India. In addition, as of the same date, Emcure Pharmaceuticals had been granted 220 patents had 30 pending patent applications in several countries, and had submitted 102 drug master files (DMFs) for APIs with the U.S. Food and Drug Administration (USFDA).

Emcure Pharmaceuticals has 13 manufacturing facilities across India. The company has witnessed substantial sales expansion in India over the recent years. Its sales in India accounted for 48.28% of the total revenue from operations during FY 2024.


The Objectives of the Issue

  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
  • General corporate purposes

Emcure Pharma IPO Timetable

IPO Opening date03 July 2024
IPO Closing05 July 2024
Basis of Allotment08 July 2024
Initiation Refund09 July 2024
Credit to Demat Account09 July 2024
Listing Date10 July 2024
(Cut-off time for UPI mandate confirmation – 5 PM on July 5, 2024)

Emcure Pharma IPO details

Issue typeBook Built Issue IPO
IPO issue size₹1,952.03 Cr – 19,365,346 shares
Fresh Issue₹800 Cr – 7,936,507 shares
Offer for sale₹1,152.03 Cr – 11,428,839 shares
Face value₹10 per share
Price Band ₹960 to ₹1008 per share
Lot size14 Shares
Employee Discount₹90 per share
Shareholding pre-issue180,852,116
Shareholding post-issue188,788,623
Listing ExchangeBSE & NSE

Emcure Pharma IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)114₹14,112
Retail (Max)14196₹197,568
S-HNI (Min)15210₹211,680
S-HNI (Max)70980₹987,840
B-HNI (Min)71994₹1,001,952

Emcure Pharma Offer Documents


Emcure Pharma IPO Reservation Details

Investor CategoryShares OfferedMaximum Allottees 
Anchor Investor Shares Offered5,779,850 (29.67%)NA
QIB Shares Offered3,853,234 (19.78%)NA
NII (HNI) Shares Offered2,889,926 (14.83%)
  bNII > ₹10L1,926,618 (9.89%)9,174
  sNII < ₹10L963,309 (4.94%)4,587
Retail Shares Offered6,743,160 (34.61%)481,654
Employee Shares Offered108,900 (0.56%)NA
Total Shares Offered19,483,388 (100%)

Emcure Pharma Financial Performance

 FY 2022FY 2023FY 2024
Revenue5,855.395,985.816,658.25
Expenses4,946.315,278.365,978.08
Net income702.56561.85527.58
Margin (%)12.009.397.92
(Amount in ₹ Crores)

Emcure Pharma Valuations & Margins

FY 2022FY 2023FY 2024
(Pre Issue)
FY 2024
(Post-Issue)*
EPS36.5529.3627.4926.34
PE Ratio34.92 – 36.6636.44 – 38.26
FY 2022FY 2023FY 2024
RONW (%)33.3221.2716.87
NAV109.69138.03162.93
ROCE (%)29.6922.0119.37
EBITDA (%)23.5420.2419.01
Debt/Equity0.990.830.67

Company Promoters

  • Satish Mehta
  • Sunil Mehta

Promoter Holding

Pre Issue Share Holding98.90%
Post Issue Share Holding78.24%

Emcure Pharma IPO GMP Update

DateDay-wise IPO GMPKostakSubject to Sauda
9 July 20243603,900
8 July 20243654,100
6 July 20243553,900
5 July 20243203,500
4 July 20243103,500
3 July 20242823,300
2 July 20242753,200
1 July 20242602,900
29 June 20242503,000

Comparison With Listed Peers

CompanyPE ratioEPSRONW (%)NAVRevenue (Cr.)
Emcure
Pharmaceuticals
36.6627.4916.87162.936,658.25
Dr. Reddy’s
Laboratories
17.93334.5919.741,693.7528,011.10
Cipla Limited30.1051.0115.43330.7825,774.09
Alkem Laboratories33.86150.1917.41862.4612,667.58
Torrent
Pharmaceuticals
57.7448.9424.15202.5710,728.0
Mankind Pharma45.3047.6820.43233.7310,334.78
Abbott India47.43565.2832.481,740.715,848.91
J. B. Chemicals &
Pharmaceuticals
50.4935.6618.90188.373,484.18

Emcure Pharma IPO Subscription Update

CategorySubscription (times)
QIB191.24
NII49.32
    bNII (bids above ₹10L)54.90
    sNII (bids below ₹10L)38.16
Retail7.36
Employee8.81
Total67.87
(Total Application : 2,845,226 (5.91 times))

Emcure Pharma IPO Allotment Status

Emcure Pharma IPO allotment status will be available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.


Emcure Pharma IPO Listing Details

Listing Date10 July 2024
BSE Scrip Code544210
NSE SymbolEMCURE
ISININE168P01015
Final Issue Price₹1008 per share

Emcure Pharma IPO Listing Day Update

Listing ExchangeBSENSE
Final Issue Price₹1,008.00₹1,008.00
Open₹1,325.05₹1,325.05
Low₹1,325.05₹1,325.05
High₹1,384.00₹1,385.00
Last Trade₹1,358.85₹1,359.15

Emcure Pharma IPO Lead Manager(s)

  • Kotak Mahindra Capital Company Limited
  • Axis Capital Limited
  • J.P. Morgan India Private Limited
  • Jefferies India Private Limited

Emcure Pharma Registrar

Link Intime India Private Limited 
C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg,
Vikhroli (West), Mumbai 400 083, Maharashtra, India
Phone: +91 810 811 4949
Email: emcure.ipo@linkintime.co.in
Website: www.linkintime.co.in


Emcure Pharma Contact Details

EMCURE PHARMACEUTICALS LIMITED
Plot No. P-1 and P-2, IT-BT Park, Phase II,
M.I.D.C., Hinjawadi, Pune 411 057, Maharashtra
Phone: +91 20 3507 0033, +91 20 3507 0000
Email: investors@emcure.com
Website: www.emcure.com


Emcure Pharma IPO FAQs

How many shares in Emcure Pharma IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply in Emcure Public Offer?

The best way to apply in Emcure public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.

What is Emcure Pharma IPO GMP today?

Emcure Pharma IPO GMP today is ₹ 360 per share.

What is Emcure IPO kostak rate today?

Emcure IPO kostak rate today is NA per application.

What is Emcure Pharma Subject to Sauda rate today?

Emcure Pharma Subject to Sauda rate today is ₹ 3,900 per application.


Final thoughts

Emcure Pharma IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. Study the company well and subscribe if you feel good about it. I hope this post will give you enough details to research the company fundamentally. learn well and make wise decisions.

Happy Investing

Leave a Comment

Your email address will not be published. Required fields are marked *